Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 318.40
-8.50 (-2.60%)
At close: Jan 30, 2026
Evogene Market Cap
Evogene has a market cap or net worth of 27.76 million as of January 30, 2026. Its market cap has decreased by -31.77% in one year.
Market Cap
27.76M
Enterprise Value
36.61M
Revenue
26.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
318.40
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 27.76M, a decrease of -75.47%. That is a compound annual growth rate of -7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 27.76M | 5.94% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 478.85M |
| Geffen Residence & Renewal | 258.75M |
| Matricelf | 154.29M |
| Clal Biotechnology Industries | 47.37M |
| BioLineRx | 41.77M |
| BioLight Life Sciences | 35.39M |
| XTL Biopharmaceuticals | 25.55M |
| Purple Biotech | 20.44M |